The Rest Study

The study drug is a potential new treatment for disturbance of sleep and its associated complications in patients with rare genetic neurological (brain) disorders such as Rett Syndrome and Fragile X Syndrome.

These disorders can result in mental and physical disorders, including sleep disorders. There is currently no specific drug approved to treat sleep disorders in patients with these conditions.

The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.